A new class of drugs for BNCT? Borylated derivatives of ferrocenium compounds in animal experiments

BioMetals

Volumn 14, Issue 1, 2001, Pages 43-49

  Weissfloch, L ^a   Wagner, M ^b   Probst, T ^c   Senekowitsch Schmidtke, R ^a   Tempel, K ^d   Molls, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Boron neutron capture therapy (BNCT); Cancer therapy; Ferrocene; Murine tumor models; Neurological toxicity

Indexed keywords

BORON DERIVATIVE; FERROCENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOMA; ATOMIC EMISSION SPECTROMETRY; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG PENETRATION; GLIOBLASTOMA; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN;

ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; FEMALE; FERROUS COMPOUNDS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H;

ANIMALIA; MURINAE; RODENTIA;

EID: 0035041197     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016686321179     Document Type: Article

References (20)

1. On the calibration curve for the determination of boron in tissue by quantitative neutron capture radiography
2. The radiation biology of boron neutron capture therapy
3. Multistep redox processes and intramolecular charge-transfer in ferrocene-based 2,2′-bipyridylboronium salts
4. Anaesthesia of Common Laboratory Species - Small Rodents
5. Boron neutron capture therapy: Principles and potentials
6. The role of chemistry in the development of boron neutron capture therapy of cancer
7. Structural features and electrochemical properties of ansa-ferrocenes with pyrazabole bridges
8. Novel ansa-ferrocenes with o-phenylene- type bridges by B-N adduct formation
9. Synthesis, structure and dynamic behavior of ansa-ferrocenes with pyrazabole bridges
10. Ferrocenium salts - The first antineoplastic iron compounds
11. Ferricenium complexes: A new type of water-soluble antitumor agent
12. Non-platinum-group metal antitumor agent: History, current status and perspectives
13. Measurement of tumour clonogenes in situ
14. Biological effects and therapeutic possibilities of neutrons
15. Methods for boron analysis in boron neutron capture therapy (BNCT). A review
16. A comparison of ICP-AES and ICP-MS with quantitative neutron capture radiography for the determination of boron in biological samples from cancer therapy
17. The rationale and requirements for the development of boron neutron capture therapy of brain tumors
18. The chemistry of neutron capture therapy
19. Oxygen tensions in rodent tumors after irradiation with neutrons